The emergence of inflammatory bowel disease in the Asian Pacific region

Current Opinion in Gastroenterology

Volumn 21, Issue 4, 2005, Pages 408-413

  Ouyang, Qin ^a   Tandon, Rakesh ^b   Goh, Khean Lee ^c   Ooi, Choon Jin ^d   Ogata, Haruhiko ^e   Fiocchi, Claudio ^f  

^a SICHUAN UNIVERSITY   (China)

^b Pushpawati Singhania Research Institute   (India)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Asia; Inflammatory bowel disease; Inflammatory bowel disease emergence; Inflammatory bowel disease epidemiology

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; APPENDECTOMY; ASIA; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; HUMAN; INCIDENCE; INDIAN; INTESTINE TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAYSIA; MALE; ONSET AGE; PACIFIC OCEAN; PREVALENCE; REVIEW; RISK FACTOR; SMOKING; ULCERATIVE COLITIS;

ASIA; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; PREVALENCE;

EID: 21844439780     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31:1-20.
2. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504-1517. A comprehensive review of the worldwide epidemiology of IBD.
3. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001; 7:260-270.
4. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000; 43(10 Suppl):S85-S93.
5. Yang SK, Hong WS, Min YI, et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000; 15:1037-1042.
6. Law NM, Lim CC, Chong R, Ng HS. Crohn's disease in the Singapore Chinese population. J Clin Gastroenterol 1998; 26:27-29.
7. Lee YM, Fock K, See SJ, et al. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000; 15:622-625.
8. Ooi CJ. Inflammatory bowel disease. In: Clinical Approach to Medicine, Second edition. Ong YY, Woo KT, Ng HS, et al., editors. Clinical approach to medicine. 2nd ed. World Scientific (in press).
9. Pongprasobchai S, Manatsathit S, Leelakusolvong S, et al. Ulcerative colitis in Thailand: a clinical study and long term follow-up. J Med Assoc Thai 2001; 84:1281-1288.
10. Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002; 8:158-161.
11. Hu RW, Ouyang Q, Chen X, et al.: An epidemiology, diagnosis and management status of inflammatory bowel disease cases in China - a literature review of Chinese database (in press).
12. Leang R, Sung JY. Inflammatory bowel disease in China: epidemiology, genetics and serology. 2004 APDW IBD Working Party, 2004.
13. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004; 10:646-651. A detailed study of Chinese patients from Hong Kong showing that the incidence of CD is increasing in this population, but with important epidemiological and phenotypic differences with CD in whites, including lack of familial clustering, male predominance and a more frequent involvement of the upper gastrointestinal tract.
14. APDW 2004 IBD Working Group. Clinical analysis of 3100 hospitalized ulcerative colitis: a retrospective nationwide survey in China from 1990-2003 in China [abstract]. J Gastroenterol Hepatol 2004; 19:A311.
15. APDW 2004 IBD Working Group. A survey of hospitalized Crohn's disease in China - a retrospective nationwide survey [abstract]. J Gastroenterol Hepatol 2004; 19:A567.
16. A retrospective analysis of hospitalized ulcerative colitis: a nationwide multicenter survey. 2004 APDW IBD Working Party, 2004.
17. Zheng JJ, Zhu XS, Huangfu Z, et al. Current status of Crohn's disease in mainland China: a systemic analysis of 50 years literature. 2004 APDW IBD Working Party, 2004.
18. Khosla SN, Girdhar NK, Lal S, Mishra DS. Epidemiology of ulcerative colitis and select general population of northern India. J Assoc Physicians India 1986; 34:405-407.
19. Sood A, Midha V, Sood N, et al. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52:1587-1590.
20. Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995; 30:1-4.
21. Ling KL, Ooi CJ, Luman W, et al. Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state. J Clin Gastroenterol 2002; 35:144-148.
22. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.
23. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
24. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357:1925-1928.
25. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123:86-91.
26. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003; 11:6-16.
27. 2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol 2004; 10:1069-1071. A study confirming and expanding the observation that mutations of the NOD2/CARD15 gene are not associated with CD in Asian populations.
28. 15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003; 17:1465-1470.
29. Kinouchi Y, Matsumoto K, Negoro K, et al. HLA-B genotype in Japanese patients with Crohn's disease. Dis Colon Rectum 2003; 46(10 Suppl):S10-S14.
30. Myung SJ, Yang SK, Jung HY, et al. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis 2002; 17:233-237.
31. Lee Y-T, Sung J-J, Poon P, et al. Association of HLA class-II genes and antineutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33:623-627.
32. Xia B, Crusius JB, Wu J, et al. CTLA4 gene polymorphisms in Dutch and Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37:1296-1300.
33. Obana N, Takahashi S, Kinouchi Y, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene CD14. Scand J Gastroenterol 2002; 37:699-704.
34. Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995; 30(Suppl 8):5-8.
35. Park ER, Yang SK, Myung SJ, et al. Familial occurrence of ulcerative colitis in Korea. Korean J Gastroenterol 2000; 36:770-774.
36. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease. A case control study of ulcerative colitis in relation to dietary and other factors in Japan. J Gastroenterol 1995; 30(Suppl 8):9-12.
37. Naganuma M, Iizuka B, Torii A, et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123-1126.
38. Nam SW, Yang SK, Jung HY, et al. Appendectomy and the risk of developing ulcerative colitis: results after control of smoking factor. Korean J Gastroenterol 1998; 32:55-60.
39. Tan YM, Goh KL. Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation in Malaysian patients. World J Gastroenterol (in press).
40. Kumar S, Ghoshal UC, Aggarwal R, et al. Severe ulcerative colitis: prospective study of parameters determining outcome. J Gastroenterol Hepatol 2004; 19:1247-1252. A report confirming that severe IBD is more common in Northern Indians than in other Asian populations.
41. Okada M, Sakurai T, Yao T, et al. Clinical course and long-term prognosis of Crohn's disease in Japan. J Gastroenterol 1994; 29:406-414.
42. Hiwatashi N, Yao T, Watanabe H, et al. Long-term follow-up study of ulcerative colitis in Japan. J Gastroenterol 1995; 30(Suppl 8):13-16.
43. Iida M, Yao T, Okada M. Long-term follow-up study of Crohn's disease in Japan. The Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995; 30(Suppl 8):17-19.
44. Pokharna RK, Kabra PK, Sharma R, Kochar DK. Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India. Indian J Gastroenterol 2004; 23:89-90.
45. Chinese Society of Gastroenterology. Suggested guideline for the diagnosis and treatment of inflammatory bowel disease. Chin J Digestion 2001; 2: 202-208.
46. A retrospective analysis of 515 hospitalized Crohn's Disease in China - A nationwide study from 1990-2003. 2004 APDW IBD Working Party, 2004.
47. Gan HT, Ouyang Q, Bu H. Polymerase chain reaction assay in differentiating intestinal tuberculosis from Crohn's disease. Chin J Digestion 2001; 21: 215-218.
48. Tsai CH, Chen HL, Ni YH, et al. Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children. J Formos Med Assoc 2004; 103:685-691. A large retrospective study characterizing the incidence in childhood IBD in East Asian patients, and demonstrating a recent marked increase in the incidence of CD among Taiwanese children.
49. Phavichitr N, Cameron DJ, Catto-Smith AG. Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 2003; 18: 329-332.
50. Chen X, Ouyang Q, Hu RW. An analysis of current treatment studies of ulcerative colitis from Chinese literatures (in press).
51. Wen ZH, Zhang H, Ouyang Q. Current status of therapeutic trails on ulcerative colitis in China. Chin J Gastroenterol 2001; 6:5-6.
52. Kohgo Y, Hibi T, Chiba T, et al. Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial. Ther Apher 2002; 6:255-260.
53. Sawada K, Muto T, Shimoyama T, et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003; 9:307-321.
54. Hanai H, Watanabe F, Takeuchi K, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003; 1:28-35.
55. Sakata H, Kawamura N, Horie T, et al. Successful treatment of ulcerative colitis with leukocytapheresis using non-woven polyester filter. Ther Apher Dial 2003; 7:536-539.
56. Naganuma M, Funakoshi S, Sakuraba A, et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 2004; 10:251-257. A clinical study showing the steroid-sparing effect of granulocytapheresis in patients whose UC is steroid-refractory or steroid-dependent.
57. Matsui T, Nishimura T, Matake H, et al. Granulocytapheresis for Crohn's disease: a report on seven refractory patients. Am J Gastroenterol 2003; 98: 511-512.
58. Ito H, Takazoe M, Fukuda Y, et al. A pilot randomized trial of a human antiinterleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004; 126:989-996. This is the first clinical trial demonstrating the potential efficacy of blocking interleukin-6 signaling as a novel therapeutic approach to CD.